Research feed
Recently published diabetes studies added to Dediabetes, summarized and organized by intervention and outcome.
Sorted by publication date. Some studies may have been added to Dediabetes later.
This study investigated the effects of Limosilactobacillus reuteri supplementation on the subgingival microbiome in diabetic patients, finding no significant alterations.
This study investigated the effects of probiotic supplementation on glycemic control in adults with type 2 diabetes. Results showed no statistically significant improvements in key glycemic markers.
This study evaluated the efficacy of Sarcomeal supplement and vitamin D3 on muscle parameters in diabetic sarcopenia patients, revealing significant improvements in lean body mass and lean mass index.
This study evaluated the CamAPS FX algorithm with simplified meal announcement against carbohydrate counting in youth and young adults with type 1 diabetes, finding non-inferiority in glucose control.
This small trial analysis tested daily tadalafil in people with type 2 diabetes. Tadalafil lowered some blood biomarkers related to amyloid metabolism and astroglial activation, but it did not change several other brain-related biomarkers.
A values-guided self-management intervention showed potential to improve glucose control in emerging adults with type 1 diabetes.
This study evaluated the effects of adjunctive vildagliptin therapy during Ramadan fasting in adolescents and young adults with type 1 diabetes, finding significant improvements in glucose management.
This study investigated the effects of Vitamin D3 supplementation alongside scaling and root planing in patients with Type 2 Diabetes Mellitus and periodontitis, finding significant improvements in periodontal health indicators.
This study investigated the effects of Vitamin D3 supplementation on oxidative stress markers and NLRP3 gene expression in patients with Type 2 Diabetes, finding significant increases in vitamin D3 levels and reductions in NLRP3 expression.
The ASCEND study investigated cardiovascular events in diabetic participants through a randomized controlled trial involving aspirin and omega-3 fatty acid supplementation.
Latest Evidence
Build your workspace to keep track of the latest diabetes research.
